NCT06849180
- Conditions
- Combined Hepatocellular Carcinoma and Cholangiocarcinoma, Combined Hepatocellular and Cholangiocarcinoma, Combined Hepatocellular-cholangiocarcinoma, +6 more
- Locations
-
- Zhongda Hospital Nanjing, Jiangsu, China
Clinical trial condition
Combined Hepatocellular Carcinoma and Cholangiocarcinoma
Explore clinical trials studying Combined Hepatocellular Carcinoma and Cholangiocarcinoma. Study availability and eligibility vary by location and protocol.
2 public trials
1 recruiting study
Combined Hepatocellular Carcinoma and Cholangiocarcinoma trial results
Active, Not Recruiting
A Study to Determine Whether Chemotherapy and Atezolizumab is Better Than Chemotherapy, Bevacizumab and Atezolizumab in Patients With Advanced Liver Cancer
NCT05211323
- Conditions
- Combined Hepatocellular Carcinoma and Cholangiocarcinoma, Digestive System Diseases, Digestive System Neoplasms, +6 more
- Locations
-
- Sutter Auburn Faith Hospital Auburn, California, United States
- Alta Bates Summit Medical Center-Herrick Campus Berkeley, California, United States
- Palo Alto Medical Foundation-Fremont Fremont, California, United States
- Memorial Medical Center Modesto, California, United States